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Synthesis and Radiolabeling of
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by Henry Rapoport,* Andrew L. Waterhouse,*
Charles M. Thompson,* and John F. O'Connell*
The imidazoquinoline and imidazoquinoxaline food mutagens found in cooked meat are being synthe-
sized by unambiguous methods that allow for the preparation of sufficient quantities of material for
biological studies. These methods avoid difficult separations of regioisomeric mixtures of products and
are designed to allow incorporation of specific high level tritium labeling.
Synthesis of 10 and MelQ
In 1980, two highly mutagenic heterocyclic amines
were isolated from cooked meats, 2-amino-3-methylim-
idazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylim-
idazo[4,5-f]quinoline (methyl IQ, MeIQ) (1,2). Both of
these compounds have been synthesized, but by some-
what limited methods (3-5). Their structures are shown
in Figure 1.
We have recently completed the synthesis of IQ and
MeIQ (6). In devising our syntheses we had three pri-
mary objectives in mind: (1) the syntheses should avoid
regioisomeric problems with their concomitant struc-
tural ambiguities and chromatographic separations; (2)
the methods should permitthe preparation oflarge (- 10
g) amounts of final product to support the necessary
biological studies; and (3) thesyntheses should be adapt-
able to the preparation of radiolabeled product which
contains label that is both site-specific and ofhigh spe-
cific activity to facilitate small scale and low efficiency
biological studies.
All of these objectives have been met, and the
syntheses are described in Figures 2 through 6.
The synthesis of IQ is shown in Figures 2 and 3. It
proceeds from 6-bromoquinoline. The bromine is then
displaced and the methylamino group unambiguously
introduced togive6-methylamino-5-nitroquinoline. This
is then reduced to the diamino compound, a key inter-
mediate. To close the imidazole ring, eitheroftwometh-
ods are used. Ifammonium formate is used, the 2-amino
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group is then introduced via the C-2 anion and reaction
with phenylazide. If cyanogen bromide is used, the 2-
amino group accompanies ring closure.
The synthesisoftritium-labeled IQis showninFigure
3. For this purpose, IQ is brominated to give the 5-
bromo compound as the only isomer. The bromine atom
is then replaced by tritium using tritium gas with a
palladium catalyst. Thus IQ is available with specific
activity up to 17 Ci/mmole. This synthesis can be easily
adapted forthe preparation of10 gram quantities ofIQ.
The synthesis ofMeIQ is shown in Figures 4, 5, and
6. It begins with the tosyl derivative of the known 2-
bromo-3-methylaniline (7). This is nitrated and the de-
sired nitro isomer is obtained after the only isomer sep-
aration in the sequence. The direction ofquinoline ring
formation is controlled by the bromo substituent. Re-
duction and methylation then gives the required meth-
ylaminoquinoline (Fig. 4).
Nitration now gives the nitramine which on warming
in acid rearranges to the nitroquinoline (Fig. 5). Re-
duction with hydrazine and Raney nickel proceeds to
the diamine with retention of the bromo substituent.
As in the case of IQ, reaction with BrCN closes the
imidazole ring and forms 5-bromoMeIQ. To prepare
MeIQ the bromine is removed by hydrogenolysis with
1H2; to prepare [5-3H1]-MeIQ, hydrogenolysis is carried
out with 3H2 (Fig. 6). This synthesis also results in
significant (-10 g) quantities of MeIQ, and the tritium
label is site-specific (C-5) and of high specific activity.
Should a 14C label be desired, this can be obtained in
both syntheses by using Br14CN. This would put a 14C
at position 2.RAPOPORT ET AL.
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FIGURE 1. Structures of IQ and MeIQ.
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FIGURE 4. Synthesis of8-bromo-7-methyl-6-methylaminoquinoline.
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FIGURE 3. Synthesis of3H-IQ.
Synthesis of the
Imidazoquinoxalines
With the same objectives in mind, namely, syntheses
that are regiochemically unambiguous, can be carried
out on a large scale, and allow the introduction of ra-
diolabel, we have planned a new approach for the syn-
thesis of the imidazoquinoxalines. The specific com-
pounds we are synthesizing are the following six: 8-
methyland 7-methyl IQx; 4,8 and 5,8-dimethyl IQx; and
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FIGURE 6. Synthesis of MeIQ.
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FIGURE 8. Photocyclization of a styrylimidazole to an imidazona-
phthalene.
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FIGURE 9. Photocyclization of a styrylpyrazine to a diazaphenan-
threne.
4,7 and 5,7-dimethyl IQx.
Some ofthese imidazoquinoxalines are powerful mu-
tagens recently isolated from fried beef(8). A synthesis
has been developed (9), but the process presents two
potential regioisomer problems. In one step, conden-
sation of a diamine with methylglyoxal did indeed give
equal quantities of both regioisomers. In the other in-
stance, nitrationapparentlygaveonly oneisomer. How-
ever, since yields were not reported, the effectiveness
of this synthesis remains in doubt.
We have patterned our synthetic strategy for the
preparation of these angular tricyclic molecules on the
methodsthathaveprovedmostsuccessfulfortheparent
tricycle phenanthrene (Fig. 7). These methods all de-
pend on an intermediate stilbene in which the central
ringis formed by anumberofcyclization processes. The
FIGURE 10. Synthesis of 1,5-substituted-N-methylimidazoles.
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FIGURE 11. Synthesis of imidazole derivatives.
most versatile cyclization method is photocyclization,
and this process has been recently comprehensively re-
viewed (10). The overwhelmingnumberofexamples are
for substituted phenanthrenes, as illustrated in Figure
7. Final aromatization is achieved by removal of H2 by
oxidation or removal of HBr with base.
Although application of this method to heterocycles
is much more limited, sufficient evidence exists to in-
dicate its potential. Thus the styrylimidazole has been
successfully photocyclized to the imidazonaphthalene
(13) as shown in Figure 8. Also, a styrylpyrazine has
been photocyclized to the corresponding diazaphenan-
threne (14) shown in Figure 9. Both of these reactions
are oxidative photocyclization in which two hydrogens
are removed from the dihydro intermediate. Alterna-
tive processes are also available in which a bromine
atom is situated at one of the cyclization positions and
aromatization is accomplished by dehydrobromination
with alkali. We have successfully carried out cycliza-
tions by both oxidative and dehydrobrominative pro-
cedures. Thus the literature clearly documents that
both "half' reactions proceed well. Both the imidazole
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FIGURE 12. Synthesis of an imidazolyl pyrazinylethylene.
and pyrazine rings will undergo this photocyclization
reaction with abenzene ring. Whatremained tobe dem-
onstrated, and what we have now accomplished in the
laboratory, is the photocyclization of imidazoles with
pyrazines to yield imidazoquinoxalines.
To proceed with our syntheses, a number ofN-meth-
ylimidazoles were required ofunambiguous regiochem-
istry. Forthispurpose weadaptedthe syntheticmethod
ofJones (13) shown in Figure 10. Large amounts ofthe
imidazole intermediates are thus available, and these
are readily transformed into the required further sub-
stitution products shown in Figure 11.
Using these imidazoles and the anion of the readily
available 2,5-dimethylpyrazine, we carried out a con-
densation to obtain the ketone. The ketone was reduced
tothe alcoholwhich wasdehydratedtothedisubstituted
ethylene. This ethylene corresponds totheprevious sty-
renes and its synthesis is shown in Figure 12.
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With the imidazolyl pyrazinyl ethylene in hand, we
proceeded to the photocyclization. Although both oxi-
dative and dehydrobrominative photocyclizations led to
imidazoquinoxalines, the dehydrobrominative method
gave better yields. The final step, replacement of the
SCH3 group by amino, was successful, but the yields
werepoor. Improvements arebeingsoughtinvariations
of the SCH3 group. This synthesis of MeIQx is illus-
trated in Figure 13.
To introduce the methyl group needed for the 5-
methyl analog, we returned to the intermediate ketone.
The enolate ion was formed with sodium hydride then
alkylated with methyl iodide. Reduction to the alcohol,
elimination, and dehydrobrominative photocyclization
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FIGURE 14. Synthesis of 5,8-dimethyl IQx.
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FIGURE 16. Introduction of radiolabel into the imidazoquinoxalines.
then led to 5,8-dimethylIQx. This sequence is given in
Figure 14.
The corresponding4-methylanalogispreparedbythe
sequence shown in Figure 15. Again, the ketone is the
key intermediate. With the methyl Grignard reagent,
thisketoneisconverted totertiaryalcohol. Dehydration
gives the substituted stilbene which is dehydrobromi-
natively photocyclized. The corresponding 7-methyl an-
alogs are made by the directly parallel route starting
with 2,6-dimethylpyrazine.
The opportunities for introducing radiolabels, both
14C and H, are presented in Figure 16. To introduce
the 3H label, the nucleus will be nitrated, and the nitro
group will be replaced by bromo via the amino deriv-
ative. Hydrogenolysis will then replace Br by 3H. The
possibilities forintroducing 14C aremanybyourmethod
of synthesis, and a 14C label can be present at C-2, C-
3a, C-4, and C-lOb.
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